title: Role of Ca2+ in the early stages of murine adipocyte differentiation as evidenced by calcium mobilizing agents.
abstract: We have investigated the effect of the endoplasmic reticulum Ca(2+)-ATPase inhibitor thapsigargin and the calcium ionophore A23187 on the differentiation of 3T3-L1 preadipocytes. Treatment of 3T3-L1 preadipocytes with either agent resulted in a dose-dependent inhibition of adipocyte differentiation. The cells accumulated neither fat droplets nor the adipocyte-specific mRNAs encoding stearoyl-CoA desaturase 1 (SCD1) and adipocyte-P2 (aP2). These late markers of differentiation were specifically affected, because thapsigargin and A23187 did not inhibit the expression of beta-tubulin mRNA. No inhibition of differentiation or the expression of the mRNAs occurred when the drugs were added either prior to or 2 days after the initiation of differentiation. Thapsigargin and A23187 were also shown to dramatically block cell proliferation and DNA replication, which occur early in differentiation. Furthermore, during the first 48 h, thapsigargin and A23187 mediated an elevated and prolonged expression of the immediate-early gene corresponding to c-myc, and altered intracellular levels of calcium. Our results suggests that changes in intracellular calcium levels elicited by thapsigargin and A23187 prevent differentiation of 3T3-L1 preadipocytes into adipocytes by blocking the postconfluent mitotic phase of the differentiation process and also by mediating c-myc gene expression.
authors.affiliation: Department of Biochemistry, University of Wisconsin-Madison 53706, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Ntambi
authors.forename: T
authors.initials: T
authors.lastname: Takova
mesh_terms: D033962:Adaptor Protein Complex 2; D033965:Adaptor Protein Complex alpha Subunits; D033942:Adaptor Proteins, Vesicular Transport; D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects*; D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000032:analysis / Q000502:physiology*; D000252:Calcium-Transporting ATPases / Q000037:antagonists & inhibitors; D018797:Cell Cycle Proteins / Q000096:biosynthesis / Q000187:drug effects / Q000235:genetics; D002454:Cell Differentiation / Q000187:drug effects; D004247:DNA / Q000187:drug effects / Q000378:metabolism; D004791:Enzyme Inhibitors; D018507:Gene Expression Regulation, Developmental; D016259:Genes, myc; D005989:Glycerides / Q000096:biosynthesis; D008565:Membrane Proteins / Q000096:biosynthesis / Q000187:drug effects / Q000235:genetics; D051379:Mice; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis / Q000187:drug effects / Q000235:genetics; D012333:RNA, Messenger / Q000187:drug effects; D013230:Stearoyl-CoA Desaturase; D013729:Terpenes / Q000494:pharmacology; D019284:Thapsigargin; D013936:Thymidine / Q000378:metabolism; D014158:Transcription, Genetic
chemical_list: D033962:Adaptor Protein Complex 2; D033965:Adaptor Protein Complex alpha Subunits; D033942:Adaptor Proteins, Vesicular Transport; D018797:Cell Cycle Proteins; D004791:Enzyme Inhibitors; D005989:Glycerides; D008565:Membrane Proteins; D011518:Proto-Oncogene Proteins; D012333:RNA, Messenger; D013729:Terpenes; D000001:Calcimycin; D019284:Thapsigargin; D004247:DNA; C490333:Scd1 protein, mouse; D013230:Stearoyl-CoA Desaturase; D000252:Calcium-Transporting ATPases; D002118:Calcium; D013936:Thymidine